MAPT and Alzheimer disease: Furthermore, butyrate mitigates tau hyperphosphorylation and reduces the expression of inflammation-related proteins, such as glial fibrillary acidic protein, by inhibiting histone acetylation, thereby alleviating AD pathology (Cao et al., 2018).